journal of men's health
Volume 8, Supplement 1 , Pages S25-S28, April 2011

Treatment of benign prostatic hyperplasia and aging: Impacts of alpha-1 blockers on sexual function

  • Satoru Takahashi

      Affiliations

    • Department of Urology, Nihon University School of Medicine 30-1, Oyaguchikamimachi, ltabashi-ku, Tokyo, 173-8610, Japan. Tel:+81 3 3972 8111; fax: +81 3 3972 5970
  • ,
  • Kenya Yamaguchi

      Affiliations

    • Department of Urology, Nihon University School of Medicine, Tokyo, Japan
  • ,
  • Sakura Clinical Study Group

Abstract 

Background

Alpha-1 blockers are the first option for the medical treatment of benign prostatic hyperplasia (BPH), and differ in their likelihood of causing abnormal ejaculation. Alpha 1A-selective blockers may result in reduced or absent seminal emission via inhibition of smooth muscle contraction. A new alpha-1 blocker, silodosin is 162 times more selective for alpha-1A than for alpha-1B, and is approximately 55 times more selective for alpha-1A than for alpha-1D. In contrast, naftopidil is an alpha 1D-selective blocker, which has been recently reported to less likely induce ejaculatory disorders. To investigate clinical efficacies and impacts on sexual function of these alpha-1 blockers in patients with BPH, we performed a multicenter randomized trial.

Methods

Eighty-nine patients with of lower urinary tract symptoms (LUTS)/BPH who had International Prostate Symptom Scores (IPSS) of 8 or more were randomly assigned to receive silodosin (8mg/day, n = 48) or naftopidil (75mg/day, n = 41). Before and 4, 8, and 12 weeks after treatment, IPSS, and Quality of Life (QOL) were employed to assess LUTS. Also, IIEF-5 and an original questionnaire were used to evaluate erectile function and ejaculation, respectively.

Results

Efficacies on LUTS of these blockers are almost equivalent, with a small advantage of silodosin on voiding symptoms. A significant impairment of ejaculation (decreases of ejaculatory volume) was observed in the silodosin group (p < 0.01). Orgasm and satisfaction on ejaculation in the silodosin group was significantly inferior to those in the naftopidil group.

Conclusions

Alpha 1D-selective blockers may possess superior property of preserving sexual function, compared with Alpha 1A-selective blockers.

Keywords:  Benign prostatic hyperplasia , Alpha-1 blockers , Alpha-1 adrenoreceptor subtypes , Sexual function , Ejaculation

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1875-6867(11)60015-8

doi:10.1016/S1875-6867(11)60015-8

journal of men's health
Volume 8, Supplement 1 , Pages S25-S28, April 2011